Sami Corwin
Stock Analyst at William Blair
(4.83)
# 451
Out of 4,966 analysts
435
Total ratings
58.6%
Success rate
20%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sami Corwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OBX Obsidian Therapeutics | Initiated Coverage: Buy | $43 | $17.80 | +141.57% | 1 | Sep 9, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | n/a | $22.03 | - | 12 | Sep 9, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | n/a | $23.99 | - | 31 | Sep 8, 2026 | |
| RARE Ultragenyx Pharmaceutical | Downgraded: Hold | n/a | $14.30 | - | 14 | Sep 5, 2026 | |
| QURE uniQure | Initiated Coverage: Buy | $73 | $44.51 | +64.01% | 30 | Sep 2, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Hold | n/a | $65.68 | - | 15 | Aug 31, 2026 | |
| CRSP CRISPR Therapeutics AG | Reiterated: Buy | n/a | $51.72 | - | 21 | Aug 28, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | n/a | $1.78 | - | 29 | Aug 13, 2026 | |
| CABA Cabaletta Bio | Reiterated: Buy | n/a | $2.73 | - | 28 | Aug 13, 2026 | |
| KYTX Kyverna Therapeutics | Reiterated: Buy | n/a | $7.26 | - | 13 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $35.48 | - | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.70 | - | 20 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.64 | - | 16 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.01 | - | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $347.00 | - | 20 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $23.30 | -19.53% | 1 | May 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.35 | - | 23 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $20.45 | - | 20 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $66.06 | - | 41 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $18.64 | - | 18 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.91 | - | 15 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.90 | n/a | 15 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.43 | n/a | 5 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.02 | n/a | 4 | Feb 1, 2023 |
Obsidian Therapeutics
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $17.80
Upside: +141.57%
Tyra Biosciences
Sep 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.03
Upside: -
Beam Therapeutics
Sep 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $23.99
Upside: -
Ultragenyx Pharmaceutical
Sep 5, 2026
Downgraded: Hold
Price Target: n/a
Current: $14.30
Upside: -
uniQure
Sep 2, 2026
Initiated Coverage: Buy
Price Target: $73
Current: $44.51
Upside: +64.01%
BioMarin Pharmaceutical
Aug 31, 2026
Reiterated: Hold
Price Target: n/a
Current: $65.68
Upside: -
CRISPR Therapeutics AG
Aug 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $51.72
Upside: -
Allogene Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.78
Upside: -
Cabaletta Bio
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.73
Upside: -
Kyverna Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.26
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $35.48
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.70
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.64
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.01
Upside: -
Aug 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $347.00
Upside: -
May 2, 2026
Initiated Coverage: Buy
Price Target: $19
Current: $23.30
Upside: -19.53%
Feb 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.35
Upside: -
Feb 26, 2026
Reiterated: Hold
Price Target: n/a
Current: $20.45
Upside: -
Feb 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $66.06
Upside: -
Nov 12, 2025
Reiterated: Hold
Price Target: n/a
Current: $18.64
Upside: -
Nov 11, 2025
Reiterated: Hold
Price Target: n/a
Current: $2.91
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $1.90
Upside: n/a
Dec 22, 2023
Rated: Hold
Price Target: n/a
Current: $15.43
Upside: n/a
Feb 1, 2023
Reiterated: Buy
Price Target: n/a
Current: $5.02
Upside: n/a